EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 173 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,533,585 | -26.4% | 97,247 | -9.3% | 0.00% | – |
| Q2 2023 | $2,084,609 | -39.1% | 107,233 | -11.2% | 0.00% | -100.0% |
| Q1 2023 | $3,425,763 | -0.9% | 120,753 | +2.1% | 0.00% | 0.0% |
| Q4 2022 | $3,458,611 | +12.8% | 118,324 | +2.0% | 0.00% | 0.0% |
| Q3 2022 | $3,065,000 | -57.7% | 115,999 | -28.9% | 0.00% | -50.0% |
| Q2 2022 | $7,247,000 | +4.4% | 163,101 | +16.2% | 0.00% | +100.0% |
| Q1 2022 | $6,943,000 | -5.3% | 140,307 | -2.6% | 0.00% | 0.0% |
| Q4 2021 | $7,334,000 | -11.7% | 144,031 | -3.3% | 0.00% | 0.0% |
| Q3 2021 | $8,307,000 | +26.7% | 148,922 | -2.8% | 0.00% | 0.0% |
| Q2 2021 | $6,555,000 | +17.1% | 153,164 | +14.2% | 0.00% | 0.0% |
| Q1 2021 | $5,600,000 | -12.4% | 134,163 | -2.3% | 0.00% | 0.0% |
| Q4 2020 | $6,396,000 | +3.0% | 137,357 | -6.0% | 0.00% | 0.0% |
| Q3 2020 | $6,210,000 | -14.8% | 146,170 | -3.7% | 0.00% | -50.0% |
| Q2 2020 | $7,286,000 | +17.2% | 151,831 | +12.3% | 0.00% | 0.0% |
| Q1 2020 | $6,217,000 | -22.5% | 135,145 | +1.2% | 0.00% | 0.0% |
| Q4 2019 | $8,021,000 | +3.3% | 133,505 | -2.7% | 0.00% | 0.0% |
| Q3 2019 | $7,762,000 | -4.2% | 137,216 | -5.8% | 0.00% | 0.0% |
| Q2 2019 | $8,106,000 | +10.7% | 145,597 | +0.4% | 0.00% | 0.0% |
| Q1 2019 | $7,324,000 | +24.7% | 145,068 | -0.5% | 0.00% | 0.0% |
| Q4 2018 | $5,875,000 | -53.4% | 145,805 | -19.8% | 0.00% | -33.3% |
| Q3 2018 | $12,603,000 | +1.2% | 181,780 | +10.5% | 0.00% | 0.0% |
| Q2 2018 | $12,452,000 | +76.6% | 164,571 | +23.0% | 0.00% | +50.0% |
| Q1 2018 | $7,049,000 | +2.8% | 133,798 | +4.3% | 0.00% | 0.0% |
| Q4 2017 | $6,854,000 | -13.4% | 128,303 | -3.3% | 0.00% | 0.0% |
| Q3 2017 | $7,913,000 | -12.5% | 132,685 | +15.7% | 0.00% | -33.3% |
| Q2 2017 | $9,046,000 | -6.7% | 114,646 | -1.9% | 0.00% | 0.0% |
| Q1 2017 | $9,692,000 | +10.8% | 116,857 | +6.0% | 0.00% | 0.0% |
| Q4 2016 | $8,745,000 | +16.5% | 110,219 | +2.8% | 0.00% | +50.0% |
| Q3 2016 | $7,507,000 | +79.4% | 107,249 | -0.6% | 0.00% | +100.0% |
| Q2 2016 | $4,185,000 | +3.0% | 107,882 | +7.5% | 0.00% | 0.0% |
| Q1 2016 | $4,065,000 | -53.6% | 100,366 | +1.7% | 0.00% | -66.7% |
| Q4 2015 | $8,752,000 | +23.2% | 98,700 | +2.9% | 0.00% | +50.0% |
| Q3 2015 | $7,102,000 | +238.5% | 95,929 | +269.7% | 0.00% | +100.0% |
| Q2 2015 | $2,098,000 | +394.8% | 25,947 | +156.2% | 0.00% | – |
| Q1 2015 | $424,000 | -4.5% | 10,127 | -67.4% | 0.00% | – |
| Q2 2014 | $444,000 | – | 31,024 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 113,737 | $3,227 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 236,883 | $6,720,371 | 0.82% |
| Capital Impact Advisors, LLC | 13,607 | $386,031 | 0.47% |
| TANG CAPITAL MANAGEMENT LLC | 80,000 | $2,269,600 | 0.34% |
| BRANDES INVESTMENT PARTNERS, LP | 545,050 | $15,463,069 | 0.33% |
| Watershed Asset Management, L.L.C. | 9,496 | $269,402 | 0.33% |
| Jackson Creek Investment Advisors LLC | 25,164 | $714 | 0.30% |
| SummerHaven Investment Management, LLC | 18,178 | $515,710 | 0.30% |
| Virtus Fund Advisers, LLC | 1,117 | $31,689 | 0.22% |
| Virtus Investment Advisers, Inc. | 7,308 | $207,328 | 0.14% |